Filing Details
- Accession Number:
- 0001384101-22-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-13 08:19:22
- Reporting Period:
- 2022-06-10
- Accepted Time:
- 2022-06-13 08:19:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1539796 | Marc Stapley | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-06-10 | 60,000 | $16.33 | 159,761 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents weighted average purchase price. Purchase prices for the transactions range from $16.24 to $16.40. Detailed information regarding the number of shares purchased at each separate price will be provided to the SEC, the issuer or a shareholder upon request.